Free Trial

China Daily tweets (about 10 mins ago):.......>

CHINA
CHINA: China Daily tweets (about 10 mins ago):
"China's #COVID19 vaccine trial, the 1st such #vaccine to reach phase 1 clinical
trial, has been found to be safe, well-tolerated, and able to generate an immune
response against SARS-COV-2 in humans, according to a study published online on
Friday by medical journal #TheLancet."
https://twitter.com/ChinaDaily/status/1263844030691057665

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.